|Articles|August 18, 2022
An Innovative Excipient-Enhanced Growth Formulation for Treatment of Lung Cancer
Author(s)Lonza
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
2
PharmTech Weekly News Roundup – Week of January 26, 2026
3
Vetter Announces Plan to Build Manufacturing Site in Germany with €1.5 Billion CDMO Investment
4
Navigating the Complex Risks of Accelerated Pharmaceutical Launches
5